CYP2A6 and the plasma level of 5-chloro-2,4-dihydroxypyridine are determinants of the pharmacokinetic variability of tegafur and 5-fluorouracil, respectively, in Japanese patients with cancer given S-1

  • FUJITA Ken-ichi
    Department of Medical Oncology, Comprehensive Cancer Center, Saitama Medical University
  • YAMAMOTO Wataru
    Department of Medical Oncology, Comprehensive Cancer Center, Saitama Medical University
  • ENDO Shoji
    Department of Medical Oncology, Comprehensive Cancer Center, Saitama Medical University
  • ENDO Hisashi
    Department of Medical Oncology, Comprehensive Cancer Center, Saitama Medical University
  • NAGASHIMA Fumio
    Department of Medical Oncology, Comprehensive Cancer Center, Saitama Medical University
  • ICHIKAWA Wataru
    Department of Medical Oncology, Comprehensive Cancer Center, Saitama Medical University
  • TANAKA Ryuhei
    Department of Medical Oncology, Comprehensive Cancer Center, Saitama Medical University
  • MIYA Toshimichi
    Department of Medical Oncology, Comprehensive Cancer Center, Saitama Medical University
  • ARAKI Kazuhiro
    Department of Medical Oncology, Comprehensive Cancer Center, Saitama Medical University
  • KODAMA Keiji
    Department of Medical Oncology, Comprehensive Cancer Center, Saitama Medical University
  • SUNAKAWA Yu
    Department of Medical Oncology, Comprehensive Cancer Center, Saitama Medical University
  • NARABAYASHI Masaru
    Department of Medical Oncology, Comprehensive Cancer Center, Saitama Medical University
  • MIWA Keisuke
    Department of Medical Oncology, Comprehensive Cancer Center, Saitama Medical University
  • ANDO Yuichi
    Department of Medical Oncology, Comprehensive Cancer Center, Saitama Medical University
  • AKIYAMA Yuko
    Department of Medical Oncology, Comprehensive Cancer Center, Saitama Medical University
  • KAWARA Kaori
    Department of Medical Oncology, Comprehensive Cancer Center, Saitama Medical University
  • KAMATAKI Tetsuya
    Department of Medical Oncology, Comprehensive Cancer Center, Saitama Medical University
  • SASAKI Yasutsuna
    Department of Medical Oncology, Comprehensive Cancer Center, Saitama Medical University

この論文をさがす

収録刊行物

被引用文献 (2)*注記

もっと見る

参考文献 (33)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ